Progress Against Lung Cancer. 1970–1979 Progress Against Lung Cancer 1970–1979 Mid-1970s:...
-
Upload
nathan-nelson -
Category
Documents
-
view
215 -
download
0
Transcript of Progress Against Lung Cancer. 1970–1979 Progress Against Lung Cancer 1970–1979 Mid-1970s:...
Progress Against Lung
Cancer
Progress Against Lung Cancer
1970–1979
Progress Against Lung Cancer
1970–1979Mid-1970s: Chemotherapy combinations prove effective in small cell lung cancer
Progress Against Lung Cancer
1980–1989
Progress Against Lung Cancer
1980–19891986: Second-hand smoke formally declared a carcinogen
Progress Against Lung Cancer
1980–19891987: Scientists discover key genetic vulnerability in tumor cells – EGFR
Progress Against Lung Cancer
1990–1999
Progress Against Lung Cancer
1990–19991990–1992: Combining chemotherapy and radiation prolongs survival for non-small cell lung cancer
Progress Against Lung Cancer
1990–19991993: Simultaneous radiation and chemotherapy boosts survival for small cell lung cancer
Progress Against Lung Cancer
1990–1999Mid-1990s: New generation of chemotherapy drugs for non-small cell lung cancer
Progress Against Lung Cancer
1990–19991995: Analysis affirms benefits of chemotherapy for advanced non-small cell lung cancer
Progress Against Lung Cancer
1990–19991996: Topotecan approved as second round of treatment for small cell lung cancer
Progress Against Lung Cancer
1990–19991999: Cranial radiation reduces risk of small cell lung cancer spreading to the brain
1999: Simultaneous chemotherapy and radiation proven most effective for stage III non-small cell lung cancer
1999: Giving radiation to the chest twice-daily increases survival for small cell lung cancer
Progress Against Lung Cancer
2000–Present
Progress Against Lung Cancer
2000–Present2000: Study links household radon exposure to lung cancer
2000: Second round of chemotherapy boosts survival in advanced non-small cell lung cancer
Progress Against Lung Cancer
2000–Present2003: First targeted drug approved for non-small cell lung cancer
Progress Against Lung Cancer
2000–Present2004: Studies show that specific EGFR mutations are associated with response to gefitinib
2004: FDA approves second targeted drug, erlotinib, for non-small cell lung cancer
2004–2005: Adjuvant therapy proven effective in lung cancer
Progress Against Lung Cancer
2000–Present2005: Anti-angiogenic drug bevacizumab extends survival for advanced lung cancer
2005: New project to map lung cancer genome
Progress Against Lung Cancer
2000–Present2008: Circulating tumor cells in the blood can help track treatment response in select patients
Progress Against Lung Cancer
2000–Present2009: Maintenance therapy improves survival for advanced non-small cell lung cancer
Progress Against Lung Cancer
2000–Present2010: Older patients should be considered for the same aggressive chemotherapy as younger patients
2010: Adding palliative care to standard chemotherapy improves survival for advanced lung cancer patients
2010: New lung cancer staging system is adopted
2010: Drug aimed at a newly identified target causes dramatic tumor shrinkages
2010: CT scanning reduces lung cancer deaths among heavy smokers
Progress Against Lung Cancer
Five-Year Survival
11
12
13
14
15
16
17
18
19
1975
1977
1979
1981
1983
1985
1987
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
2009
Year of Diagnosis
% o
f Pa
tien
ts S
urv
ivin
g F
ive
Ye
ars
Source: National Cancer Institute
Progress Against Lung Cancer
Mortality
32
37
42
47
52
57
62
1970
1972
1974
1976
1978
1980
1982
1984
1986
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
2010
Year of Death
Ca
nce
r D
ea
ths
pe
r 1
00
,00
0 P
eo
ple
Source: National Cancer Institute
Progress Against Lung Cancer
New Cases
46
51
56
61
66
71
1973
1975
1977
1979
1981
1983
1985
1987
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
2009
Year of Diagnosis
Ne
w C
an
cer
Ca
ses
pe
r 1
00
,00
0 P
eo
ple
Source: National Cancer Institute
Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers
CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and
research new cures